Results 181 to 190 of about 449,138 (190)

Cannabis Resin Extract in Parkinson’s Disease: Behavioral, Neurochemical, and Histological Evaluation

Cell Biology: Research & Therapy, 2014
Cannabis sativa (Family Cannabaceae, L.) has been used in China and India for thousands of years as a medicine. The main active constituents of cannabis are Δ 9 -tetrahydrocannabinol (THC), cannabinol (CBN) and cannabidiol (CBD). Currently, THC and CBD are being carefully used in conditions, such as multiple sclerosis, cancer pain, and chemotherapy ...
openaire   +1 more source

PARKINSON’S DISEASE CLASSIFICATION USING HYBRID NAMIB SQUIRREL SEARCH WATER ALGORITHM-BASED DEEP LEARNING APPROACH

International Journal for Multiscale Computational Engineering
Parkinson's disease (PD) is a neurological disease throughout the globe, and it is the second leading reason for death and impairment. The overall cases of PD have nearly doubled in the past 15 years. It has been defined by the absence of dopamine cells in the brain.
S. Sharanyaa, Jimsha K. Mathew, Kavitha R. Nair, Muthulakshmi Arumugasamy   +3 more
openaire   +1 more source

Parkinson’s disease and hospital admissions: frequencies, diagnoses and costs

Acta Neurologica Scandinavica, 2010
C. Vossius, O. B. Nilsen, J. P. Larsen
openaire   +1 more source

Expression of LIF and LIF receptor beta in Alzheimer’s and Parkinson’s diseases

Acta Neurologica Scandinavica, 2010
M. Soilu-Hänninen, E. Broberg, M. Röyttä, P. Mattila, J. Rinne, V. Hukkanen   +5 more
openaire   +1 more source

A Comparative Study of Sleep Disorders between Familial and Sporadic Parkinson’s Disease

International Journal of Neurology and Neurosurgery, 2017
openaire   +1 more source

The use of psilocybin for the management of Parkinson’s disease. Systematic literature review. 2023

openaire   +1 more source